• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Minority-Serving Hospitals are Associated with Lower Likelihood of Providing NCCN Guideline Compliant Care to Patients with Resectable Cholangiocarcinoma.

作者信息

Tsilimigras Diamantis I, Pawlik Timothy M

机构信息

Division of Surgical Oncology, Department of Surgery, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

出版信息

Ann Surg Oncol. 2021 Dec;28(13):8172-8173. doi: 10.1245/s10434-021-10211-x. Epub 2021 May 20.

DOI:10.1245/s10434-021-10211-x
PMID:34018087
Abstract
摘要

相似文献

1
ASO Author Reflections: Minority-Serving Hospitals are Associated with Lower Likelihood of Providing NCCN Guideline Compliant Care to Patients with Resectable Cholangiocarcinoma.ASO作者反思：服务少数族裔的医院为可切除胆管癌患者提供符合NCCN指南护理的可能性较低。
Ann Surg Oncol. 2021 Dec;28(13):8172-8173. doi: 10.1245/s10434-021-10211-x. Epub 2021 May 20.
2
Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.少数民族服务医院与非少数民族服务医院在可切除胆管癌的 NCCN 指南规范治疗方面的差异。
Ann Surg Oncol. 2021 Dec;28(13):8162-8171. doi: 10.1245/s10434-021-10202-y. Epub 2021 May 25.
3
ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma.《美国外科医师学会（ASO）作者反思：新辅助治疗在可手术切除的肝内胆管癌中的作用》
Ann Surg Oncol. 2021 Oct;28(11):6736-6737. doi: 10.1245/s10434-020-09541-z. Epub 2021 Jan 15.
4
ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.ASO作者反思：可切除性肝内胆管癌新辅助治疗后术前分期及降期的准确性
Ann Surg Oncol. 2023 Aug;30(8):4809-4810. doi: 10.1245/s10434-023-13485-5. Epub 2023 Apr 12.
5
ASO Author Reflections: Bile Duct Resection-Is It Beneficial for Distal Cholangiocarcinoma?ASO作者反思：胆管切除术——对远端胆管癌有益吗？
Ann Surg Oncol. 2021 Apr;28(4):2000. doi: 10.1245/s10434-020-09171-5. Epub 2020 Oct 22.
6
ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.ASO作者反思：可切除胰腺导管腺癌和远端胆管癌全身治疗的时机与术后发病率
Ann Surg Oncol. 2023 Aug;30(8):5035. doi: 10.1245/s10434-023-13581-6. Epub 2023 May 13.
7
ASO Author Reflections: Laparoscopic Resection of the Middle Bile Duct for Cholangiocarcinoma: How We Do It (with Video).ASO作者反思：腹腔镜下胆管癌中段胆管切除术：我们的手术方法（附视频）
Ann Surg Oncol. 2024 Feb;31(2):1278-1279. doi: 10.1245/s10434-023-14567-0. Epub 2023 Nov 11.
8
ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.ASO作者反思：肝内胆管癌：降期策略为手术和治愈打开大门。
Ann Surg Oncol. 2020 Oct;27(10):3738-3739. doi: 10.1245/s10434-020-08489-4. Epub 2020 Apr 20.
9
ASO Author Reflections: Is Major Hepatopancreatoduodenectomy Beneficial for Patients with Advanced and Widespread Extrahepatic Cholangiocarcinoma?
Ann Surg Oncol. 2021 Apr;28(4):2026-2027. doi: 10.1245/s10434-020-09261-4. Epub 2020 Oct 21.
10
ASO Author Reflections: Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma-Opportunities and Challenges.《美国外科医师学会（ASO）作者反思：腹腔镜手术治疗肝内胆管癌——机遇与挑战》
Ann Surg Oncol. 2024 May;31(5):3104-3105. doi: 10.1245/s10434-024-14971-0. Epub 2024 Jan 30.